Dr. Mark Ware, former vice-chair of the Task Force on Cannabis Legalization and Regulation, has joined Canopy Growth as the company's Chief Medical Officer.
Ware is an associate professor of family medicine and anesthesia at McGill University and has spent 20 years researching cannabis for pain management. Now, he will be handling Canopy's clinical research and will be developing educational materials.
"I am very excited about the opportunity to join Canopy and to further develop global cannabis research" said Dr. Ware following the announcement. "This approach is needed to more effectively respond to the needs of patients and healthcare professionals worldwide."
Canopy CEO Bruce Linton says bringing on Ware is part of their commitment to developing rigorous research for the medicinal cannabis industry to pull from.
"His knowledge and expertise strengthen our ability to research and develop sophisticated cannabis medicines capable of improving patients' lives around the world, while providing further clinical evidence as healthcare practitioners and governments are calling for."